Unknown

Dataset Information

0

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?


ABSTRACT: The emergent outbreak of coronavirus disease 2019 (COVID-19) has caused a global pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are among the leading causes of death in critically ill patients with COVID-19. The elevated inflammatory cytokines suggest that a cytokine storm, also known as cytokine release syndrome (CRS), may play a major role in the pathology of COVID-19. However, the efficacy of corticosteroids, commonly utilized antiinflammatory agents, to treat COVID-19-induced CRS is controversial. There is an urgent need for novel therapies to treat COVID-19-induced CRS. Here, we discuss the pathogenesis of severe acute respiratory syndrome (SARS)-induced CRS, compare the CRS in COVID-19 with that in SARS and Middle East respiratory syndrome (MERS), and summarize the existing therapies for CRS. We propose to utilize interleukin-6 (IL-6) blockade to manage COVID-19-induced CRS and discuss several factors that should be taken into consideration for its clinical application.

SUBMITTER: Liu B 

PROVIDER: S-EPMC7151347 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Liu Bingwen B   Li Min M   Zhou Zhiguang Z   Guan Xuan X   Xiang Yufei Y  

Journal of autoimmunity 20200410


The emergent outbreak of coronavirus disease 2019 (COVID-19) has caused a global pandemic. Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are among the leading causes of death in critically ill patients with COVID-19. The elevated inflammatory cytokines suggest that a cytokine storm, also known as cytokine release syndrome (CRS), may play a major role in the pathology of COVID-19. However, the efficacy of corticosteroids, commonly utilized antiinflammatory agents, to treat  ...[more]

Similar Datasets

| S-EPMC7649275 | biostudies-literature
| S-EPMC7314334 | biostudies-literature
| S-EPMC6410714 | biostudies-literature
| S-EPMC7831876 | biostudies-literature
| S-EPMC7790281 | biostudies-literature
2023-06-17 | GSE234676 | GEO
2023-06-17 | GSE234673 | GEO
2023-06-17 | GSE234668 | GEO
| S-EPMC10732679 | biostudies-literature
| S-EPMC6483278 | biostudies-literature